| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AGA
|
aspartylglucosaminidase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANXA5
|
annexin A5
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATXN1
|
ataxin 1
|
|
AURKA
|
aurora kinase A
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BLNK
|
B-cell linker
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CBX1
|
chromobox homolog 1
|
|
CBX3
|
chromobox homolog 3
|
|
CCDC50
|
coiled-coil domain containing 50
|
|
CCND1
|
cyclin D1
|
|
CD300LB
|
CD300 molecule-like family member b
|
|
CDC6
|
cell division cycle 6
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK1
|
checkpoint kinase 1
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
DAXX
|
death-domain associated protein
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DNM1L
|
dynamin 1-like
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
ETV6
|
ets variant 6
|
|
EXOSC9
|
exosome component 9
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO3
|
forkhead box O3
|
|
G6PC
|
glucose-6-phosphatase, catalytic subunit
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLI2
|
GLI family zinc finger 2
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
H2AFX
|
H2A histone family, member X
|
|
H2AFY
|
H2A histone family, member Y
|
|
H3F3A
|
H3 histone, family 3A
|
|
H3F3B
|
H3 histone, family 3B (H3.3B)
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC6
|
histone deacetylase 6
|
|
HDAC7
|
histone deacetylase 7
|
|
HDAC8
|
histone deacetylase 8
|
|
HERC2
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2
|
|
HEXIM1
|
hexamethylene bis-acetamide inducible 1
|
|
HIST1H1A
|
histone cluster 1, H1a
|
|
HIST1H1E
|
histone cluster 1, H1e
|
|
HIST1H2BB
|
histone cluster 1, H2bb
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HIST1H3B
|
histone cluster 1, H3b
|
|
HIST3H2BA
|
histone cluster 3, H2ba, pseudogene
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
ILK
|
integrin-linked kinase
|
|
INSR
|
insulin receptor
|
|
IRF2BP2
|
interferon regulatory factor 2 binding protein 2
|
|
IRS1
|
insulin receptor substrate 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRT8
|
keratin 8, type II
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LIPE
|
lipase, hormone-sensitive
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MDM4
|
MDM4, p53 regulator
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MVB12B
|
multivesicular body subunit 12B
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
NEFM
|
neurofilament, medium polypeptide
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NOP58
|
NOP58 ribonucleoprotein
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR2C1
|
nuclear receptor subfamily 2, group C, member 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRIP1
|
nuclear receptor interacting protein 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OXSR1
|
oxidative stress responsive 1
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PGR
|
progesterone receptor
|
|
PHF8
|
PHD finger protein 8
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PILRA
|
paired immunoglobin-like type 2 receptor alpha
|
|
PLEK
|
pleckstrin
|
|
PML
|
promyelocytic leukemia
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP1R2
|
protein phosphatase 1, regulatory (inhibitor) subunit 2
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7
|
|
PXN
|
paxillin
|
|
PYGL
|
phosphorylase, glycogen, liver
|
|
RB1
|
retinoblastoma 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRM2
|
ribonucleotide reductase M2
|
|
SDC4
|
syndecan 4
|
|
SET
|
SET nuclear proto-oncogene
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIK1
|
salt-inducible kinase 1
|
|
SIK2
|
salt-inducible kinase 2
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMC3
|
structural maintenance of chromosomes 3
|
|
SMYD2
|
SET and MYND domain containing 2
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK39
|
serine threonine kinase 39
|
|
SUB1
|
SUB1 homolog (S. cerevisiae)
|
|
SYK
|
spleen tyrosine kinase
|
|
SYT2
|
synaptotagmin II
|
|
TBX21
|
T-box 21
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRHR
|
thyrotropin-releasing hormone receptor
|
|
TRIM28
|
tripartite motif containing 28
|
|
TTK
|
TTK protein kinase
|
|
TTN
|
titin
|
|
VCP
|
valosin containing protein
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YY1
|
YY1 transcription factor
|
|
ZFYVE28
|
zinc finger, FYVE domain containing 28
|
